US Patent Issued to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM on July 1 for "Transgenic bacteria with expanded amino acid usage and nucleic acid molecules for use in the same" (Texas Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,344,879, issued on July 1, was assigned to BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (Austin, Texas).

"Transgenic bacteria with expanded amino acid usage and nucleic acid molecules for use in the same" was invented by Andrew D. Ellington (Austin, Texas) and Ross Thyer (Austin, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "Recombinant bacterial cells are provided that comprise a stable non-canonical amino acid translation pathway. In some aspects, the bacteria comprise nucleic acids encoding a non-canonical amino acid translation pathway (e.g., a tRNA for incorporation of a non-canonical amino acid, such selenocysteine); a marker polypeptide...